MetLife Investment Management’s Agilon Health AGL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $428K | Buy |
186,002
+132
| +0.1% | +$304 | ﹤0.01% | 1758 |
|
2025
Q1 | $805K | Buy |
185,870
+11,319
| +6% | +$49K | ﹤0.01% | 1468 |
|
2024
Q4 | $332K | Buy |
174,551
+6,762
| +4% | +$12.8K | ﹤0.01% | 2015 |
|
2024
Q3 | $659K | Buy |
167,789
+89,675
| +115% | +$352K | ﹤0.01% | 1630 |
|
2024
Q2 | $511K | Buy |
78,114
+61,740
| +377% | +$404K | ﹤0.01% | 1711 |
|
2024
Q1 | $99.9K | Buy |
16,374
+51
| +0.3% | +$311 | ﹤0.01% | 2539 |
|
2023
Q4 | $205K | Sell |
16,323
-228
| -1% | -$2.86K | ﹤0.01% | 2232 |
|
2023
Q3 | $294K | Buy |
16,551
+830
| +5% | +$14.7K | ﹤0.01% | 1969 |
|
2023
Q2 | $273K | Buy |
15,721
+4,764
| +43% | +$82.6K | ﹤0.01% | 2074 |
|
2023
Q1 | $260K | Buy |
10,957
+26
| +0.2% | +$618 | ﹤0.01% | 2066 |
|
2022
Q4 | $176K | Sell |
10,931
-280
| -2% | -$4.52K | ﹤0.01% | 2324 |
|
2022
Q3 | $263K | Buy |
11,211
+116
| +1% | +$2.72K | ﹤0.01% | 2113 |
|
2022
Q2 | $242K | Buy |
11,095
+759
| +7% | +$16.6K | ﹤0.01% | 2182 |
|
2022
Q1 | $262K | Buy |
+10,336
| New | +$262K | ﹤0.01% | 2184 |
|